Voyager Therapeutics: 2Q Earnings Snapshot
Aug. 07, 2018
CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $25.5 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 80 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.
The gene therapy company posted revenue of $2.6 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $3 million.
Voyager Therapeutics shares have climbed 22 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $20.18, more than doubling in the last 12 months.